Nymox Pharmaceutical
NYMX
#10189
Rank
NZ$31.59 M
Marketcap
Country
NZ$0.35
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Nymox Pharmaceutical (NYMX) - Net assets

Net assets on the balance sheet as of June 2023 : -NZ$4.99 Million

According to Nymox Pharmaceutical's latest financial reports the company has -NZ$4.99 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nymox Pharmaceutical - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-NZ$0.76 Million2.48%
2021-12-31$-NZ$0.75 Million-124.92%
2020-12-31$NZ$2.97 M-41.93%
2019-12-31$NZ$5.11 M-50.95%
2018-12-31$NZ$10.43 M-692.61%
2017-12-31$-NZ$1.77 Million90.23%
2016-12-31$-NZ$0.93 Million-76.98%
2015-12-31$-NZ$4.03 Million-24.62%
2014-12-31$-NZ$5.34 Million-27.62%
2013-12-31$-NZ$7.38 Million-18.53%
2012-12-31$-NZ$9.05 Million35.89%
2011-12-31$-NZ$6.66 Million79.98%
2010-12-31$-NZ$3.71 Million85.07%
2009-12-31$-NZ$2 Million-141.28%
2008-12-31$NZ$4.84 M25.1%
2007-12-31$NZ$3.87 M49.33%
2006-12-31$NZ$2.59 M46.2%
2005-12-31$NZ$1.77 M-37.12%
2004-12-31$NZ$2.82 M-23.56%
2003-12-31$NZ$3.68 M-33.11%
2002-12-31$NZ$5.51 M-33.5%
2001-12-31$NZ$8.29 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Abbott Laboratories
ABT
NZ$88.73 B-1,781,956.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B-3,235,970.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$12.76 B-256,478.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B-829,116.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.22 B-2,755,643.97%๐Ÿ‡บ๐Ÿ‡ธ USA